StockTipsArenaBeta

BUY Zydus Lifesciences Limited — Deven Choksey, DRChoksey

BUYZydus Lifesciences Limited
Zydus Lifesciences share price target & all analyst calls

byDeven Choksey, DRChokseyHorizon: NA (inferred 1 year)25 Aug 2025via Institutional / Brokerage Research

Entry₹1,023.15Inferred
Target₹1,183
Total upside +15.62% (call closed)
Stop lossNot given
Exit₹1,18311 Aug 2026, 12:08 pm
Target hit+15.62%0.00%upside left
Follow Deven Choksey for new calls(73% target hit, 66 closed calls)Get alertsWatch ZYDUSLIFE for new buy/sell callsGet alertsSee 7 active Long-term calls on ZYDUSLIFESee 274 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 11 Aug 2026
21 supporting8 neutral4 opposing
Supports the BUY call (21)

Macquarie Hikes Zydus Lifesciences' Target Ahead Of Q1 Results; Bets On New Business Buildout To Drive Growth

NewsNdtv-Profit·11 Aug · today

(opens in new tab)

Zydus Lifesciences Ltd has launched REVAHALE, which is India's first once-daily nebulised LAMA medication for COPD.

BSE · Company Update·10 Aug · today

(opens in new tab)

2 other SEBI-registered advisors have active long-term BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·11 Aug · today

Zydus gets USFDA nod for surgical imaging drug, may get 6-month monopoly in $125 million US market

NewsCnbc-Tv18·4 Aug · 6d ago

(opens in new tab)

Zydus Lifesciences Ltd announced final approval from the USFDA for Indocyanine Green for Injection, including 180-days CGT exclusivity.

BSE · Company Update·4 Aug · 6d ago

(opens in new tab)
Neutral / worth noting (8)

Zydus Lifesciences Q1 Results Today: Time, Earnings Call, What To Watch, Share Price

NewsNdtv-Profit·11 Aug · today

(opens in new tab)

Market Pulse: Key triggers to watch before the August 11 trading session

NewsCnbc-Tv18·10 Aug · today

(opens in new tab)

Zydus Lifesciences suspends some Ahmedabad operations due to heavy rain, resumes activity

NewsCnbc-Tv18·25 Jul · 2w ago

(opens in new tab)

Corporate Actions This Week: Angel One, Bharti Airtel, Hero MotoCorp, Zydus Lifesciences And Pidilite Industries | Full List

NewsNdtv-Profit·19 Jul · 3w ago

(opens in new tab)
Weighs against the BUY call (4)

Zydus Lifesciences received an order from the Superintendent of Stamps, Gandhinagar, demanding recovery of ₹53.47 million in deficient stamp duty and ₹55.07 million in penalties, totaling ₹108.54 mill

BSE · Company Update·29 Jul · 2w ago

(opens in new tab)

The exchange sought clarification from Zydus Lifesciences Ltd regarding a media report about a Delhi High Court order temporarily restricting the supply of its cancer drug Ikra in a patent dispute.

BSE · Company Update·14 Jul · 4w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Zydus Lifesciences

All analyst calls on Zydus Lifesciences

More from Deven Choksey, DRChoksey

Every call and its outcome